<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-057291</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Should be modify hemoglobin targets in CKD patients? FDA and EMEA statements</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Aljama, P</dc:creator>
<dc:creator>Martín de Francisco, AL</dc:creator>
<dc:creator>Arias, M</dc:creator>
<dc:creator>Martínez Castelao, A</dc:creator>
<dc:creator>Portolés, J</dc:creator>
<dc:creator>Górriz, JL</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Nefrologia;27(4): 399-404, jul.-ago. 2007.</dc:source>
<dc:identifier>ibc-057291</dc:identifier>
<dc:title xml:lang="es">¿Es necesario cambiar los niveles actuales de hemoglobina diana en pacientes con enfermedad renal crónica? A propósito del «boxed warning» de la FDA y del Public Statement de la EMEA</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d29387^s22020</dc:subject>
<dc:subject>^d50497^s22032</dc:subject>
<dc:subject>^d29407</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22198^s22002</dc:subject>
<dc:subject>^d2359^s22027</dc:subject>
<dc:type>article</dc:type>
<dc:date>200708</dc:date>
</metadata>
</record>
</ibecs-document>
